Showing results (291-300 of 1,028) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.The Lancet. Respiratory Medicine|October 21, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trialAndre C Kalil, Aneesh K Mehta, Thomas F Patterson, et al.The Lancet. Respiratory Medicine|October 24, 2021
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?Gregory Milne, Thomas Hames, Chris Scotton, et al.The Lancet. Respiratory Medicine|October 15, 2021
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohortsLieuwe D J Bos, Michael Sjoding, Pratik Sinha, et al.The Lancet. Respiratory Medicine|October 11, 2021
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trialIoannis Psallidas, Maged Hassan, Ahmed Yousuf, et al.The Lancet. Respiratory Medicine|October 17, 2019
Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality DatabaseStefano Barco, Seyed Hamidreza Mahmoudpour, Luca Valerio, et al.The Lancet. Respiratory Medicine|April 26, 2022
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational studyThe Lancet. Respiratory Medicine|June 15, 2019
Effects of saline or albumin fluid bolus in resuscitation: evidence from re-analysis of the FEAST trialMichael Levin, Aubrey J Cunnington, Clare Wilson, et al.The Lancet. Respiratory Medicine|June 26, 2019
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyBenjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, et al.The Lancet. Respiratory Medicine|February 3, 2022
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label studyRuvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, et al.Pageof 103